why choose us

First received: November 28, 2022

Clinical Trial: MT Combined With XKSA for Depressive Symptoms During COVID-19

Study Status: Completed

Recruit Status: Completed

Condition: Depression, Anxiety

Study Type: Interventional


Official Title: Morita Therapy Combined With Xingnao Kaiqiao Acupressure for Relieving Depressive Symptoms During COVID-19: A Randomized Controlled Study

Brief Summary: Social isolation related mental health problems have raised many concerns during the COVID-19 outbreaks. Mental health care for people in quarantined hotels is in urgent need, but concrete program is rarely reported. Morita therapy and acupressure have been identified as effective treatments for regulating mood and sleep. The study aimed to examine whether Morita therapy (MT) combined with Xingnao Kaiqiao self-administered acupressure (XKSA) could improve depressive, anxiety symptoms and sleep quality in isolated…

Read more